Fluorocarbons as anti-inflammatory agents
AssigneeThe Research Foundation of State University of New York
InventorsBradley P. Fuhrman, Stephen F. Flaim, Lynn J. Hernan, Frances D. Nesti, Michele C. Papo, David M. Steinhorn
Life of this patent
Estimating the term…
Abstract
A method for reducing the inflammatory response in tissue of a patient, by contacting the tissue with an effective, inflammation-reducing amount of a liquid or gaseous fluorocarbon.
Claims10
A method for reducing the inflammatory response in lung of a patient in need of such treatment, comprising the step of administering an effective, inflammation-reducing amount of a fluorocarbon gas or aerosol into said lung from an external source.
A method for reducing the inflammatory response in external epidermal or mucosal tissue, comprising the step of topically contacting said tissue with an effective inflammation-reducing amount of a liquid fluorocarbon.
A method for treating a systemic inflammatory disorder in a patient, comprising the step of administering to said patient an effective inflammation-reducing amount of a liquid fluorocarbon.
A method for reducing gastrointestinal inflammation in a patient, comprising orally or rectally administering to said patient an effective inflammation-reducing amount of a fluorocarbon liquid or emulsion.
Dependencies are inferred from the claim text.